Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice

International Journal of Stroke

Volumn 7, Issue 8, 2012, Pages 649-654

  Heeley, Emma ^a   Anderson, Craig ^a   Patel, Anushka ^a   Cass, Alan ^a   Peiris, David ^a   Weekes, Andrew ^b   Chalmers, John ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Servier Laboratories (Australia) Pty Ltd   (Australia)

Author keywords

Cardiovascular disease; General practice; Myocardial infarction; Risk perception; Secondary prevention; Stroke

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

AGED; ARTICLE; AUSTRALIA; BLOOD PRESSURE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENERAL PRACTICE; HEALTH CARE DISPARITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECURRENCE RISK; SECONDARY PREVENTION; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENERAL PRACTICE; HEALTHCARE DISPARITIES; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; SECONDARY PREVENTION; STROKE;

EID: 84869058457     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00613.x     Document Type: Article

References (27)

1. World Health Organization. The Global Burden of Disease: 2004 Update. WHO Library Cataloguing-in-Publication Data, 2008, Switzerland.
2. Progress Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-41.
3. Rashid P, Leonardi-Bee J, Bath P.Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34:2741-8.
4. Smith SC Jr, Allen J, Blair SNet al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113:2363-72.
5. Law MR, Morris JK, Wald NJ.Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:1245-1253.
6. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
7. Amarenco P, Bogousslavsky J, Callahan AIIIet al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355:549-59.
8. LaRosa JC, He J, Vupputuri S.Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999; 282:2340-6.
9. National Stroke Foundation. Clinical Guidelines for the Management of Acute Stroke. Australia: National Health and Research Council, 2007.
10. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Reducing risk in heart disease 2007. Updated 2008.
11. Sacco RL, Adams R, Albers Get al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37:577-617.
12. Heeley EL, Peiris DP, Patel AAet al. Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study). Med J Aust 2010; 192:254-9.
13. Barros AJ, Hirakata VN.Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; http://www.biomedcentral.com/1471-2288/3/21
14. Holloway RG, Benesch C, Rush SR.Stroke prevention: narrowing the evidence-practice gap. Neurology 2000; 54:1899-906.
15. Touzé E, Coste J, Voicu Met al. Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study. Stroke 2008; 39:1834-43.
16. Raine R, Wong W, Ambler Get al. Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study. BMJ 2009; 338:1122-1127.
17. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U.Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373:929-40.
18. Ford ES, Ajani UA, Croft JBet al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356:2388-98.
19. Mendis S, Abegunde D, Yusuf Set al. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). Bull World Health Organ 2005; 83:820-9.
20. Mechtouff L, Touzé E, Steg PGet al. Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease. J Intern Med 2010; 267:621-33.
21. Amar J, Cambou JP, Touzé Eet al. Comparison of hypertension management after stroke and myocardial infarction: results from ECLAT1 - a French nationwide study. Stroke 2004; 35:1579-83.
22. Saposnik G, Goodman SG, Leiter LAet al. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals? Stroke 2009; 40:1417-24.
23. Alvarez-Sabin J, Quintana M, Hernandez-Presa MA, Alvarez C, Chaves J, Ribo M.Therapeutic interventions and success in risk factor control for secondary prevention of stroke. J Stroke Cerebrovasc Dis 2009; 18:460-5.
24. Rothwell PM, Giles MF, Chandratheva Aet al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007; 370:1432-42.
25. Simpson CR, Wilson C, Hannaford PC, Williams D.Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke 2005; 36:1771-5.
26. Katapodi MC, Lee KA, Facione NC, Dodd MJ.Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 2004; 38:388-402.
27. van der Weijden T, van Steenkiste B, Stoffers HE, Timmermans DR, Grol R.Primary prevention of cardiovascular diseases in general practice: mismatch between cardiovascular risk and patients' risk perceptions. Med Decis Making 2007; 27:754-61.